SCHEMBL6981434

SCHEMBL6981434

O=S(=O)(Nc1cccc2ncccc12)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 1/20 0.68
HTT P42858 4/20 0.66
SMN1; SMN2 Q16637 3/20 0.66
LMNA P02545 3/20 0.63
TDP1 Q9NUW8 2/20 0.63
TP53 P04637 2/20 0.63
ALOX15 P16050 2/20 0.63
NPSR1 Q6W5P4 2/20 0.63
TSHR P16473 1/20 0.63
OPRK1 P41145 1/20 0.63
TLR9 Q9NR96 1/20 0.63
SLC40A1 Q9NP59 9/20 0.62
G6PD P11413 1/20 0.62
NFKBIA P25963 1/20 0.62
AGTR1 P30556 1/20 0.62
METAP2 P50579 1/20 0.62
METAP1 P53582 1/20 0.62
GLO1 Q04760 1/20 0.62
PAX8 Q06710 1/20 0.62
ATM Q13315 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12220831 0.84 MCL1 (0.60) CLK1HTTSMN1; SMN2LMNATDP1
SCHEMBL2055416 0.83 CLK1 (0.62) CLK1HTTSMN1; SMN2LMNATDP1
SCHEMBL7531380 0.80 HTT (0.52) CLK1HTTSMN1; SMN2LMNATDP1
SCHEMBL3269491 0.80 SLC40A1 (0.68) TDP1SLC40A1G6PDNFKBIAAGTR1
SCHEMBL2914257 0.80 HTT (0.60) CLK1HTTSMN1; SMN2LMNATDP1
SCHEMBL3981512 0.79 METAP2 (0.65) HTTSMN1; SMN2LMNATDP1SLC40A1
SCHEMBL11973604 0.79 SLC40A1 (0.67) HTTSMN1; SMN2TDP1SLC40A1G6PD
SCHEMBL31689606 0.78 CLK1 (0.60) CLK1HTTSMN1; SMN2LMNATDP1
SCHEMBL17737443 0.78 RECQL (0.60) HTTSMN1; SMN2LMNATDP1SLC40A1
SCHEMBL1428546 0.77 RECQL (1.00) HTTSMN1; SMN2LMNATDP1SLC40A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016206101-A1 METALLO-BETA-LACTAMASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-12-29 WO disclosed
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed